CNNA Stock Overview
A development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Cann American Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0069 |
| 52 Week High | US$0.0077 |
| 52 Week Low | US$0.000001 |
| Beta | -0.038 |
| 11 Month Change | 109.09% |
| 3 Month Change | 187.50% |
| 1 Year Change | 762.50% |
| 33 Year Change | -55.77% |
| 5 Year Change | -78.44% |
| Change since IPO | -100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNNA | US Food | US Market | |
|---|---|---|---|
| 7D | 15.0% | 1.3% | -0.3% |
| 1Y | 762.5% | -11.5% | 22.3% |
Return vs Industry: CNNA exceeded the US Food industry which returned -10.5% over the past year.
Return vs Market: CNNA exceeded the US Market which returned 24.2% over the past year.
Price Volatility
| CNNA volatility | |
|---|---|
| CNNA Average Weekly Movement | 79.9% |
| Food Industry Average Movement | 4.1% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.4% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: CNNA's share price has been volatile over the past 3 months.
Volatility Over Time: CNNA's weekly volatility has increased from 51% to 80% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | n/a | Jason Tucker | www.cannamericancorp.com |
Cann American Corp., a development stage company, focuses on the development of Cannabis sativa strains for pets in various European Union countries. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was founded in 2004 and is based in Cloverdale, California.
Cann American Corp. Fundamentals Summary
| CNNA fundamental statistics | |
|---|---|
| Market cap | US$5.09m |
| Earnings (TTM) | US$3.82m |
| Revenue (TTM) | n/a |
1.3x
P/E Ratio0.0x
P/S RatioIs CNNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNNA income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | -US$3.82m |
| Earnings | US$3.82m |
Last Reported Earnings
Feb 28, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.0052 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -12.8% |
How did CNNA perform over the long term?
See historical performance and comparison